Print Page   |   Contact Us   |   Sign In   |   Register
Community Search
WCBP 2018: Call for Abstracts
Share |

Abstract submission is now closed.

Poster Abstract Due Date: 
Friday, November 17, 2017 by 5:00 pm PST
Abstracts will not be accepted after this date, no exceptions.

Poster Criteria:

Abstracts will be reviewed by a committee comprised of members from the WCBP 2018 Program Planning Committee. Abstracts will be reviewed and scored based on the criteria below. Acceptance of a poster abstract is based on the review score and the space available for displaying posters.

1. Applied research/development: Preference will be given to analyses of biological macromolecules that are product development candidates or are on the market. Model compounds (e.g. BSA, lysozyme) will tend to receive a lower rating than a clinically-relevant product.
2. Novel, high-impact methods: New analytical tools and technologies or those that have larger impact in the field will receive higher scores.
3. Quality of presentation: Clarity, legibility and succinctness of the abstract will be considered in the review. Please proofread your title and abstract prior to submission.
4. Results oriented. Abstracts must summarize the results of the study. Phrases such as “results will be discussed” are not acceptable.
5. Any vendor, company or institution will have no more than four (4) posters accepted for display. If the vendor, company, or institution chooses to rank their submitted abstracts, then the ranking will be considered along with the reviewers’ scores in determining which posters are accepted and posted.
6. Individual poster presenters will be limited to presenting one poster in a given poster session. While submission of multiple abstracts by a single presenter is not discouraged, not more than one poster per presenter will be allowed in either poster session.

For more information about posters at WCBP 2018, click here.



more Calendar

7/10/2018 » 7/12/2018
Cell & Gene Therapy Products 2018

7/16/2018 » 7/17/2018
CMC Strategy Forum Summer 2018

9/9/2018 » 9/12/2018
CE Pharm and Mass Spec 2018

Featured Members
Linda O. Narhi, Amgen Inc.Visit the CASSS News page to get to know Linda Narhi!

Membership Software Powered by YourMembership  ::  Legal